Applies to mifepristone: oral tablet
In addition to its needed effects, some unwanted effects may be caused by mifepristone. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking mifepristone:
Some of the side effects that can occur with mifepristone may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to mifepristone: oral tablet
The most commonly reported adverse reactions were nausea, weakness, fever/chills, vomiting, headache, diarrhea, and dizziness.[Ref]
Very common (10% or more): Hypertension (24%)Uncommon (0.1% to 1%): Hypotension (0.25%), hot flushRare (less than 0.1%): Myocardial infarction, induced Adam-Stokes syndrome, superficial thrombophlebitis Postmarketing reports: Syncope, fainting, loss of consciousness, hypotension (including orthostatic), light-headedness, tachycardia (including racing pulse, heart palpitations, heart pounding)[Ref]
Very common (10% or more): Thyroid function test abnormal (18%) in patients with Cushing syndrome[Ref]
It was reported that of the 42 Cushing syndrome patients with detectable TSH at baseline, eight (19%) had increases in TSH above the normal range, while remaining asymptomatic.  The TSH levels returned to normal in most patients when this drug was discontinued at the end of the study.Adrenal insufficiency was reported in two subjects (4%) in Study 400.  The most typical symptoms of adrenal insufficiency were nausea and decreased appetite.  Adrenal insufficiency resolved in both cases with interruption of this drug and/or dexamethasone administration.[Ref]
Very common (10% or more): Nausea (48%), vomiting (26%), dry mouth (18%), diarrhea (12%), constipation (10%), gastric discomfort, abdominal painCommon (1% to 10%): Light or moderate cramping Rare (less than 0.1%): Gastric bleeding, necrotising pancreatitisPostmarketing reports: Dyspepsia, gastroesophageal reflux[Ref]
Heavy bleeding occurs in about 5% of the cases and may require hemostatic curettage in up to 1.4% of the cases.In clinical trials surgical evacuation was needed in 10% to 12% of women, with some studies reporting a rate as high as 20% to 30%.  Bleeding can be prolonged for several days after prostaglandin analog administration and sometimes leads to a decrease in hemoglobin levels.[Ref]
Very common (10% or more): Uterine contractions or cramping (up to 45%) following prostaglandin intake, endometrial hypertrophy (38%), vaginal bleeding, uterine spasmCommon (1% to 10%): Endometritis, pelvic inflammatory disease, heavy uterine bleeding, prolonged post abortion bleeding, spotting, severe hemorrhage, breast tendernessUncommon (0.1% to 1%): Uterine rupture after prostaglandin intake (during induction of second trimester termination of pregnancy or labor induction for fetal death in utero during the third trimester), hemorrhagic shock, salpingitisRare (less than 0.1%): Hydatiform mole, ectopic pregnancy, amniotic band syndrome, gestational trophoblastic tumor, uteroplacental apoplexy, bilateral adnexal mass, intrauterine adhesion, ovarian cyst rupture, breast abscess, hematosalpinx, uterine rupturePostmarketing reports: Post-abortal infection (including endometritis, endomyometritis, parametritis, pelvic infection, pelvic inflammatory disease, salpingitis); hematometra, leukorrhea, vaginal hemorrhage, metrorrhagia[Ref]
Very common (10% or more): Blood potassium decreased (34%) in Cushing syndrome patientsRare (less than 0.1%): Thrombotic thrombocytopenic purpura, thrombocytopenia, induced systemic lupus erythematosusPostmarketing reports: Anemia[Ref]
In Cushing syndrome patients:Very common (10% or more): Decreased appetite (20%), anorexia (10%) Postmarketing reports: Increased triglycerides, hypoglycemia[Ref]
Very common (10% or more): Arthralgia (30%), back pain (16%), myalgia (14%), pain in the extremity (12%)Rare (less than 0.1%): Limb spasmPostmarketing reports: Muscular weakness, flank pain, musculoskeletal chest pain[Ref]
Very common (10% or more): Headache (44%), dizziness (22%), somnolence (10%)Rare (less than 0.1%): Vagal symptoms (hot flushes, dizziness, chills), epilepsy, neurogenic tinnitus[Ref]
Very common (10% or more): Fatigue (48%), peripheral edema (26%), pain (14%), chill, feverCommon (1% to 10%): FaintingRare (0.01% to 0.1%): MalaiseVery rare (less than 0.01%): Fatal toxic shock caused by Clostridium sordellii endometritis or Escherichia coli (use of mifepristone followed by non authorized vaginal administration of misoprostol oral tablets)Postmarketing reports: Asthenia, edema, pitting edema, thirst[Ref]
Very common (10% or more): Anxiety (10%)Rare (less than 0.1%): ManiaPostmarketing reports: Insomnia[Ref]
Very common (10% or more): Dyspnea (16%), sinusitis (14%), nasopharyngitis (12%)Rare (less than 0.1%): Bronchospasm, induced bronchial asthmaFrequency not reported: Shortness of breath[Ref]
Uncommon (0.1% to 1%): Skin rashes (0.2%), pruritusRare (0.01% to 0.1%): Urticaria, erythroderma, erythema nodosum, toxic epidermal necrolysis	Very rare (less than 0.01%): Angioedema[Ref]
Rare (less than 0.1%): Abnormal liver function tests, hepatic failure, hepatorenal failure[Ref]
Rare (less than 0.1%): AnaphylaxisPostmarketing reports: Allergic reaction (including anaphylaxis, angioedema, hives, rash, itching)[Ref]
Rare (less than 0.1%): Ophthalmoplegia, periorbital edema[Ref]
Rare (less than 0.1%): Elevated alpha-feto protein, elevated carcinoembryonic antigen[Ref]
Rare (less than 0.1%): Renal failure[Ref]
1. "Product Information. Mifeprex (mifepristone)" Danco Laboratories, New York, NY. 
2. "Product Information. Korlym (mifepristone)." Corcept Therapeutics Incorporated, Menlo Park, CA. 
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
4. Cerner Multum,  Inc. "Australian Product Information." O 0
Not all side effects for mifepristone may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Excessively heavy vaginal bleeding
unusual tiredness or weakness


Chest pain or discomfort
confusion
cough or hoarseness
fast, weak pulse
fever or chills
lower back or side pain
pain or discomfort in the arms, jaw, back, or neck
painful or difficult urination
pale, cold, or clammy skin
shortness of breath
sudden increase in stomach or shoulder pain
sweating
unusual or large amount of vaginal bleeding


Abdominal or stomach pain or uterine cramping
back pain
diarrhea
dizziness
headache
nausea or vomiting


Acid or sour stomach
anxiety
belching 
cough
fainting or lightheadedness when getting up from a lying or sitting position
fever
flu-like symptoms
headache
heartburn
increased clear or white vaginal discharge
indigestion
itching of the vagina or genital area
lack or loss of strength
pain during sexual intercourse
pain or tenderness around the eyes and cheekbones
pale skin
shaking chills
stomach discomfort, upset, or pain
stuffy or runny nose
tightness of the chest
trouble sleeping
troubled breathing
troubled breathing, exertional
unusual bleeding or bruising

